-
Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required )
(PAR-21-283)
National Institute of Mental Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional)
(PAR-21-284)
National Institute of Mental Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required)
(PAR-21-291)
National Institute of Mental Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required)
(PAR-21-292)
National Institute of Mental Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
(PAR-21-303)
John E. Fogarty International Center
National Cancer Institute
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Biomedical Imaging and Bioengineering
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Brazil Regional Prospective Observational Research in Tuberculosis (RePORT) (U01 Clinical Trial Not Allowed)
(PAR-21-304)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Not Applicable
-
Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required)
(PAR-21-309)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)
(PAR-21-310)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed)
(PAR-22-023)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): October 22, 2021
-
Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed)
(RFA-CA-21-052)
National Cancer Institute
Application Receipt Date(s): November 01, 2021
-
Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed)
(RFA-CA-21-053)
National Cancer Institute
Application Receipt Date(s): November 01, 2021
-
Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed)
(RFA-DK-21-010)
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 20, 2021
-
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1: Data Production Research and Development Centers (UM1 Clinical Trial Not Allowed)
(RFA-HG-21-029)
National Human Genome Research Institute
Application Receipt Date(s): November 1, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1: Data Analysis and Validation Centers (U01 Clinical Trial Not Allowed)
(RFA-HG-21-030)
National Human Genome Research Institute
Application Receipt Date(s): November 1, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1: Data Resource and Administrative Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-HG-21-031)
National Human Genome Research Institute
Application Receipt Date(s): November 1, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)
(RFA-HG-21-033)
National Human Genome Research Institute
Application Receipt Date(s): December 1, 2021; July 1, 2022; July 1, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
(RFA-HG-21-041)
National Human Genome Research Institute
Office of the Director, NIH
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): October 20, 2021
-
Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed)
(RFA-NS-22-001)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): October 22, 2021
-
Leveraging Existing Data Resources for Computational Model and Tool Development to Discover Novel Candidate Mechanisms and Biomarkers for ADRD (R01 Clinical Trial Not Allowed)
(RFA-NS-22-006)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): October 26, 2021